Intelligent Asthma Monitoring Devices Market Research 2024: Partnerships Between Pharma and Smart Inhaler Firms to Revolutionize Asthma Management - Global Long-term Forecasts to 2028 and 2033
October 17, 2024 04:01 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Intelligent Asthma Monitoring Devices Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The intelligent asthma monitoring...
Certara Appoints John Reynders as New Independent Board Member
October 16, 2024 16:15 ET
|
Certara
Certara today announced the appointment of John Reynders, PhD to its Board of Directors, effective October 15, 2024.
80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight
October 16, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- 80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight With over 80 key companies active in the RNA therapies...
Global Clinical Laboratory Service Market to Cross ~USD 400 Billion Mark by 2030 | DelveInsight
October 16, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Global Clinical Laboratory Service Market to Cross ~USD 400 Billion Mark by 2030 | DelveInsight The increasing demand for clinical laboratory...
Orally Disintegrating Tablet Market is Projected to Reach US$ 72.68 Billion with a CAGR of 11.5% by 2034 | Fact.MR Report
October 16, 2024 07:00 ET
|
FACT.MR
Rockville, MD, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Based on a new research report published by Fact.MR, the global orally disintegrating tablet market is poised to reach a valuation of US$ 24.45...
HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial
October 16, 2024 00:30 ET
|
HUTCHMED (China) Limited
— New data demonstrate efficacy for the oral treatment combination to address MET-driven resistance in EGFR-mutated lung cancer — — MET is a common biomarker in this setting for patients who...
Global Automated Cell Culture Market to Exhibit Significant Growth at a CAGR of ~7% by 2030 | DelveInsight
October 15, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Global Automated Cell Culture Market to Exhibit Significant Growth at a CAGR of ~7% by 2030 | DelveInsight The demand for automated cell culture...
Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain
October 15, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the...
Antibiotic Resistance Research Report 2024: 6 Key Large Opportunities in this Space and Developed Market Forecasts with Profiles of 100+ Biotechnology Companies
October 15, 2024 10:31 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
October 15, 2024 09:10 ET
|
SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...